Zexian Liu

University of Nottingham Ningbo China — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

57h-index24.9kcitations441works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(88), interferon and immune responses(72), Cancer-related molecular mechanisms research(65), Ubiquitin and proteasome pathways(49), Advanced Optimization Algorithms Research(35)

Publications438 total

Figure S7 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Supplementary Tables 1-2, Supplementary Figures 1-7 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Supplementary Table 3 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S1 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S4 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S2 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S5 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Supplementary Table 2 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Supplementary Table 1 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S6 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Figure S3 from TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP
2025Open Access
Supplementary Figure Legends from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Table 3 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
2025Open Access
Supplementary Figure 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Table 4 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Figure 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Table 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Methods from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
2025Open Access
Supplementary Table 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
Supplementary Table 3 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
2025Open Access
page 1 of 22Next →

Frequent Co-authors

Rui‐Hua Xu(20), Huai‐Qiang Ju(17), Yu Xue(15), Qi Zhao(15), Zhao-Lei Zeng(13), Jian Ren(10), De‐Shen Wang(8), Dan Xie(8), Feng Wang(7), Qi‐Nian Wu(7), Qi-Nian Wu(6), Zhixiang Zuo(6), Kai Yu(6), Han Cheng(5), Yun-Xin Lu(5), Xinjiao Gao(5), Yun‐Xin Lu(5), Ying Jin(4), Heng-Ying Pu(4), Hui Sheng(4)